While the clinical presentation strongly supports the diagnosis of CIPA, confirmatory tests such as skin, nerve biopsy, and genetic analysis of the neurotrophic tyrosine kinase receptor 1 (NTRK1) gene provide definitive evidence [8]. The gene discussed is NTRK1; the disease is hereditary sensory and autonomic neuropathy type 4.